Literature DB >> 8750970

Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures.

D M Bronstein1, I Perez-Otano, V Sun, S B Mullis Sawin, J Chan, G C Wu, P M Hudson, L Y Kong, J S Hong, M K McMillian.   

Abstract

Dopaminergic neurotoxicities of 6-hydroxydopamine (6-OHDA) and the lipopolysaccharide (LPS) were compared in rat mesencephalic cultures plated on poly-L-lysine or on glial monolayers. In the neuron-enriched cultures plated on polylysine, 6-OHDA killed 89% of the tyrosine hydroxylase (TH)-immunopositive neurons, but LPS was not neurotoxic. Conversely, in mixed neuron/glial cultures, 6-OHDA killed only 27% of the TH-immunopositive neurons while LPS killed 70%. The mixed neuronal/glial mesencephalic culture offers a better in vitro model for studying possible mechanisms involved in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8750970     DOI: 10.1016/0006-8993(95)01189-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  34 in total

1.  Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia.

Authors:  W G Kim; R P Mohney; B Wilson; G H Jeohn; B Liu; J S Hong
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  Allosteric modulation of the group III mGlu4 receptor provides functional neuroprotection in the 6-hydroxydopamine rat model of Parkinson's disease.

Authors:  Matthew J Betts; Michael J O'Neill; Susan Duty
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

Review 3.  Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

Authors:  Malú G Tansey; Melissa K McCoy; Tamy C Frank-Cannon
Journal:  Exp Neurol       Date:  2007-07-17       Impact factor: 5.330

Review 4.  The Nrf2-ARE cytoprotective pathway in astrocytes.

Authors:  Marcelo R Vargas; Jeffrey A Johnson
Journal:  Expert Rev Mol Med       Date:  2009-06-03       Impact factor: 5.600

Review 5.  Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Authors:  Elisabetta Vegeto; Valeria Benedusi; Adriana Maggi
Journal:  Front Neuroendocrinol       Date:  2008-04-29       Impact factor: 8.606

Review 6.  The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Gururaj Joshi; Jeffrey A Johnson
Journal:  Recent Pat CNS Drug Discov       Date:  2012-12

7.  Modulation of morphological changes of microglia and neuroprotection by monocyte chemoattractant protein-1 in experimental glaucoma.

Authors:  Kin Chiu; Sze-Chun Yeung; Kwok-Fai So; Raymond Chuen-Chung Chang
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

8.  Lysine and arginine reduce the effects of cerebral ischemic insults and inhibit glutamate-induced neuronal activity in rats.

Authors:  Takashi Kondoh; Makiko Kameishi; Hruda Nanda Mallick; Taketoshi Ono; Kunio Torii
Journal:  Front Integr Neurosci       Date:  2010-06-14

9.  The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis.

Authors:  Natalie A Prow; David N Irani
Journal:  Exp Neurol       Date:  2007-03-23       Impact factor: 5.330

10.  Effects of the combined treatment of naloxone and indomethacin on catecholamines and behavior after intranigral lipopolysaccharide injection.

Authors:  Vinchi Wang; Lie-Gan Chia; Dah-Ren Ni; Lee-Ju Cheng; Yuh-Pin Ho; Fu-Chou Cheng; Jau-Shyong Hong
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.